Stratec SE (ETR:SBS)
Germany · Delayed Price · Currency is EUR | Market Cap | 308.15M -7.8% |
| Revenue (ttm) | 244.81M -7.1% |
| Net Income | -395.00K |
| EPS | -0.03 |
| Shares Out | 12.16M |
| PE Ratio | n/a |
| Forward PE | 16.39 |
| Dividend | 0.60 (2.44%) |
| Ex-Dividend Date | Jun 24, 2026 |
| Volume | 3,511 |
| Open | 25.35 |
| Previous Close | 25.35 |
| Day's Range | 24.60 - 25.40 |
| 52-Week Range | 16.30 - 33.10 |
| Beta | 0.84 |
| Analysts | Buy |
| Price Target | 25.60 (+3.64%) |
| Earnings Date | Nov 12, 2026 |
About Stratec SE
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is h... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 6 analysts, the average rating for SBS stock is "Buy." The 12-month stock price target is €25.60, which is an increase of 3.64% from the latest price.
News
Stratec SE Slides: Investor presentation
Stratec SE has posted slides in relation to its latest quarterly earnings report, which was published on September 9, 2026.
EQS-DD: STRATEC SE: Andrea Leistner, Acquisition of 35,000 STRATEC SE shares from Ralf Leistner by way of gift
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 20.08.2026 / 18:37 CET/CEST The issuer is solely responsi...
EQS-DD: STRATEC SE: Ralf Leistner, Gift of 35,000 STRATEC SE shares to Andrea Leistner
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 20.08.2026 / 18:36 CET/CEST The issuer is solely responsi...
EQS-DD: STRATEC SE: Ralf Leistner, Acquisition of 29,556 STRATEC SE shares from Hermann Leistner and Doris Leistner by way of gift
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 20.08.2026 / 18:35 CET/CEST The issuer is solely responsi...
Stratec SE Earnings Call Transcript: Q2 2026
Q2 saw a strong rebound, narrowing the year-on-year gap in sales and earnings, with robust system business growth offsetting weak consumables. Free cash flow and profitability improved, and full-year guidance is confirmed, with growth expected to be heavily backend-loaded.
Stratec SE Quarterly report: Q2 2026
Stratec SE has published its Q2 2026 quarterly earnings report on August 14, 2026.
Stratec SE Earnings release: Q2 2026
Stratec SE released its Q2 2026 earnings on August 14, 2026, summarizing the period's financial results.
Stratec SE Slides: Q2 2026
Stratec SE has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 14, 2026.
EQS-AFR: STRATEC SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQS Preliminary announcement financial reports: STRATEC SE / Preliminary announcement on the disclosure of financial statements STRATEC SE: Preliminary announcement of the publication of financial rep...
Stratec SE Slides: Corporate presentation
Stratec SE has posted slides in relation to its latest quarterly earnings report, which was published on August 1, 2026.
Stratec SE Slides: Investor presentation
Stratec SE has posted slides in relation to its latest quarterly earnings report, which was published on July 1, 2026.
Stratec SE Earnings Call Transcript: Q1 2026
Q1 2026 saw lower revenue and earnings due to timing shifts and product mix, but cash flow and leverage improved. Guidance for 2026 is confirmed, with growth and margin recovery expected in H2, and long-term targets remain intact.
Stratec SE Quarterly report: Q1 2026
Stratec SE has published its Q1 2026 quarterly earnings report on May 11, 2026.
Stratec SE Earnings release: Q1 2026
Stratec SE released its Q1 2026 earnings on May 11, 2026, summarizing the period's financial results.
Stratec SE Slides: Q1 2026
Stratec SE has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 11, 2026.
Stratec SE Earnings Call Transcript: Q4 2025
2025 saw stable revenue but lower margins amid geopolitical and supply chain challenges, with significant one-time charges impacting net income. Growth is expected to resume in 2026, driven by new product launches and efficiency gains, with margin recovery targeted by 2028.
Stratec SE Annual report: Q4 2025
Stratec SE has published its Q4 2025 annual report on April 28, 2026.
Stratec SE Earnings release: Q4 2025
Stratec SE released its Q4 2025 earnings on April 28, 2026, summarizing the period's financial results.
Stratec SE Slides: Q4 2025
Stratec SE has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on April 28, 2026.
Stratec SE Earnings Call Transcript: Q3 2025
Sales grew 2.5% year-over-year to EUR 175.6 million, with margin pressure from product mix and supply chain issues. Full-year guidance is for flat sales and lower margins, but Q4 is expected to improve. New partnerships, a syndicated loan, and market stabilization support a positive long-term outlook.
Stratec SE Quarterly report: Q3 2025
Stratec SE has published its Q3 2025 quarterly earnings report on November 7, 2025.
Stratec SE Slides: Q3 2025
Stratec SE has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 7, 2025.